SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer

BACKGROUND: Currently, no biomarkers of response to mitomycin C have been identified in non–muscle-invasive bladder cancer patients. Predictive biomarkers could improve the treatment outcome and eliminate adverse events from unnecessary treatment. OBJECTIVE: To identify and validate predictive bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindgren, Maria Skydt, Lamy, Philippe, Lindskrog, Sia Viborg, Christensen, Emil, Nordentoft, Iver, Birkenkamp-Demtröder, Karin, Ulhøi, Benedicte Parm, Jensen, Jørgen Bjerggaard, Dyrskjøt, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Bladder Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655384/
https://www.ncbi.nlm.nih.gov/pubmed/34934968
http://dx.doi.org/10.1016/j.euros.2021.09.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655384/
https://www.ncbi.nlm.nih.gov/pubmed/34934968
http://dx.doi.org/10.1016/j.euros.2021.09.018

Ejemplares similares